ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives
Open accessThe DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index; 213 of the 289 sources its claims cite were checked for support.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) in adults has become an increasingly recognized clinical entity, with growing attention in research and healthcare settings. ADHD can significantly affect multiple domains of adult functioning, including education, employment, interpersonal relationships, and both mental and physical health. However, despite the expanding body of literature, gaps in understanding persist. This narrative review synthesizes current evidence on adult ADHD. The literature was systematically searched in databases such as PubMed, Scopus, and PsycINFO using predefined keywords related to ADHD in adults. Inclusion criteria focused on peer-reviewed articles published between 2010 and 2025, addressing epidemiology, etiology, diagnosis, treatment, and functioning. Exclusion criteria included studies with pediatric populations only or lacking methodological rigor. ADHD in adults is prevalent worldwide, with considerable heterogeneity across studies. Its etiology involves complex interactions between genetic, neurobiological, and environmental factors. Clinical presentation in adulthood differs from childhood, with symptoms such as inattention, emotional dysregulation, and executive dysfunction predominating. Diagnostic challenges include retrospective assessment of childhood symptoms and comorbidity with mood and anxiety disorders. Pharmacotherapy and cognitive–behavioral interventions show efficacy, particularly when combined in integrated care models. ADHD negatively affects quality of life and occupational and social functioning and increases the risk of comorbid disorders, including psychoactive substance use. Adult ADHD is a multifaceted condition requiring a comprehensive, multidisciplinary approach to diagnosis and management. Future research should aim to refine diagnostic tools, explore neurobiological markers, and tailor interventions to individual profiles. Expanding knowledge on adult ADHD will improve identification, treatment outcomes, and overall quality of life for affected individuals.
Overview
CoChat Summary
## TL;DR
This is a narrative review of adult ADHD that synthesizes literature from 2010–2025 on epidemiology, etiology, neurobiology, diagnosis, treatment, and functioning. It concludes that adult ADHD is common, heterogeneous, frequently comorbid, and best managed with integrated pharmacological and psychosocial care.
## Key findings
- Adult ADHD prevalence is reported as about 3%–6% in adults, with a global estimate of approximately 2.8%; the review also notes a broader range of approximately 2.5%–6.7%.
- Around 60%–65% of people diagnosed in childhood continue to have symptoms as adults, and many adults are first diagnosed late: in the USA, 55.9% were first diagnosed at age 18 or older, and one clinical/primary care study found only 25% had a childhood diagnosis.
- Psychiatric comorbidity is very common: 50%–80% of adults with ADHD have at least one additional mental disorder; mood disorders affect about 50%, anxiety disorders 20%–50%, substance use disorders carry a twofold increased risk, and emotional dysregulation is estimated in roughly 34%–70% of adults.
- Treatment evidence supports stimulants as first-line and most efficacious medications, with non-stimulants also effective; CBT is described as the most validated psychological therapy, with moderate-to-large effects on symptom reduction and comorbid anxiety/depression.
- Functional impact is substantial: adults with ADHD show lower educational attainment, more employment instability, and in one cross-national survey had 8.4 excess sick days per year.
## Methods
- Narrative review, not a meta-analysis; the authors systematically searched PubMed, Scopus, Web of Science, and PsycINFO using ADHD-adult-related keywords and Boolean operators.
- Included peer-reviewed English or Polish articles from 2010–2025 focused on adults (≥18 years) and on epidemiology, etiology, neurobiology, diagnosis, treatment, functioning, or quality of life; excluded pediatric-only studies, non-scientific items, conference abstracts without full text, poor-quality studies, and pre-2010 papers without updated relevance.
- The analysis was qualitative synthesis with narrative review of themes, with quantitative numbers extracted where applicable.
## Limitations
- The paper states that it is not a formal meta-analysis, so it cannot provide pooled effect sizes or quantitative comparisons.
- The included literature is heterogeneous in diagnostic criteria, assessment tools, and sample characteristics, which limits comparability; this is stated in the paper.
- Much of the evidence relies on retrospective self-report of childhood symptoms, which the paper notes may introduce recall bias.
- Because the search ended in 2025 and the authors note the possibility of publication bias and exclusion of very recent publications, these are evident limitations from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
128 Valid · 39 Not valid · 44 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The current evidence base supports conceptualizing ADHD–ASD overlap as a distinct hybrid phenotype rather than a mere comorbidity”
§ ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives > 2. Epidemiology of Adult ADHD > 2.1. Prevalence
What the sources say
- Disputedcites [48] Deserno, 2023, Probing the overarching continuum theory: Data-driven phenotypic clustering of children with ASD or ADHD, Eur. Child Adolesc. Psychiatry sourceExperimental — accuracy not yet measured
The Results (Community detection identifies subgroups that cross-diagnostic boundaries; page unavailable) report that children with both diagnoses appeared in multiple clusters, rather than a distinct hybrid group. The Conclusion (page unavailable) says the study cannot unambiguously characterize ADHD and ASD as separate entities or opposite ends of a spectrum. It therefore does not support presenting a distinct hybrid phenotype as the conclusion of the evidence. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Could not verifycites [49] Schweizer, T., Endres, D., Dziobek, I., and van Elst, L.T. (2024). Psychosocial therapeutic approaches for high-functioning autistic adults. Front. Psychiatry, 14. sourceExperimental — accuracy not yet measured
The Introduction and the Discussion’s ‘Overall assessment of the current evidence base’ address high-functioning autistic adults, co-occurring anxiety and depression, and psychosocial interventions. Searches for ADHD–ASD overlap and a distinct hybrid phenotype found no passage addressing that distinction in our copy. (LLM, conf=0.76)
- Disputedcites [50] Young, S., Hollingdale, J., Absoud, M., Bolton, P., Branney, P., Colley, W., Craze, E., Dave, M., Deeley, Q., and Farrag, E. (2020). Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Med., 18. sourceExperimental — accuracy not yet measured
The Background (‘Co-occurring ADHD and ASD’; page not provided) describes the overlap as co-occurrence that confers ‘additive vulnerability and complexity,’ not as a distinct hybrid phenotype. The Results (‘Identification and assessment’; page not provided) likewise discusses establishing an additional comorbid diagnosis when both conditions are present. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“This, in turn, results in attenuated phasic (task-related) DA firing in response to salient stimuli, leading to a weakened “signal-to-noise” ratio in the PFC”
§ ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives > 3. Etiology and Neurobiology of Adult ADHD > 3.2. Neurotransmitter System Dysfunctions The “catecholamine hypothesis” remains the most robust neurochemical model of ADHD, positing a primary dysregulation in dopaminergic (DA) and noradrenergic (NE) signaling. The DA system is central to executive function, motivation, and reward processing. The predominant theory suggests a state of hypodopaminergic functioning, particularly within fronto-striatal pathways. This is supported by molecular imaging (PET/SPECT), which, despite some inconsistencies, meta-analytically points to increased DA transporter (DAT) density in the striatum [66]. Higher DAT availability would lead to excessive reuptake and thus lower synaptic DA levels. A more nuanced interpretation is the “dopamine signaling” hypothesis (also known as the tonic-phasic model). This model proposes that low tonic (baseline) DA levels, particularly in the prefrontal cortex (PFC), impair the optimal “tuning” of cortical networks. This, in turn, results in attenuated phasic (task-related) DA firing in response to salient stimuli, leading to a weakened “signal-to-noise” ratio in the PFC [67]. This weakened signal impairs the maintenance of working memory and attentional focus. Concurrently, dysregulation in the mesolimbic pathway is linked to altered reward processing and the “delay aversion” characteristic of ADHD [68]. The NE system, originating from the locus coeruleus, is critical for modulating arousal, vigilance, and the “top-down” control of executive functions within the PFC. NE modulates the firing of PFC pyramidal neurons via postsynaptic α2A-adrenoceptors, enhancing relevant network signals (the “signal”) and suppressing irrelevant ones (the “noise”) [69]. Noradrenergic dysregulation is thought to contribute directly to inattention and emotional lability. The clinical efficacy of NE reuptake inhibitors (e.g., atomoxetine) and α2A-agonists (e.g., guanfacine) in treating ADHD underscores the therapeutic importance of this system [69]. Latest evidence suggests a “multi-modular” chemical imbalance. Magnetic Resonance Spectroscopy (MRS) studies have identified alterations in the glutamate-glutamine cycle—the brain’s primary excitatory system—in the PFC and striatum. Given that glutamate signaling is tightly coupled with and modulates DA release, this suggests that fronto-striatal dysfunction in ADHD may be a product of imbalanced glutamate/GABA-DA interactions [70]. The serotonergic (5-HT) system has also been implicated, particularly in relation to impulsivity and the high rates of comorbid mood and anxiety disorders [71].
What the sources say
- Disputedcites [67] Véronneau-Veilleux, F., Robaey, P., Ursino, M., and Nekka, F. (2022). A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning. Front. Comput. Neurosci., 16. sourceExperimental — accuracy not yet measured
The Results (§3.1) state the opposite relationship: in the model, lower tonic dopamine reduces autoreceptor occupancy and produces higher phasic dopamine peaks. The Discussion (§4) reports an approximately 40% increase in the phasic response. The paper does not establish the claimed weakened signal-to-noise ratio in the PFC. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Variants within the dopamine transporter gene (DAT1/SLC6A3) and the dopamine D4 receptor gene (DRD4, especially the 7-repeat allele) were repeatedly associated with increased ADHD risk”
§ ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives > 2. Epidemiology of Adult ADHD > 2.2. Risk Factors and Predictors The etiology of ADHD is most accurately conceptualized not as the consequence of a single etiological source but as a multifactorial neurodevelopmental condition arising from the interaction between genetic predisposition and environmental influences (G×E). These factors jointly shape brain development and influence the clinical emergence of ADHD across the lifespan [57,58]. Evidence from twin studies consistently demonstrates a robust genetic contribution to ADHD, with heritability estimates of approximately 74% [57,58]. This places ADHD among the most heritable psychiatric disorders, underscoring inherited neurobiological vulnerability as a central etiological component [50]. Importantly, the genetic influence on ADHD is substantial yet probabilistic—genetic liability increases susceptibility but does not determine the disorder in isolation. Initial molecular studies focused on candidate genes, particularly within dopaminergic and noradrenergic pathways, aligning with known mechanisms of stimulant medications [59]. Variants within the dopamine transporter gene (DAT1/SLC6A3) and the dopamine D4 receptor gene (DRD4, especially the 7-repeat allele) were repeatedly associated with increased ADHD risk [59,60]. These findings formed the basis of the classical dopaminergic hypothesis, emphasizing dysregulation of reward and executive function circuits. Nevertheless, individual genetic variants accounted for only small increments of risk. Subsequent genome-wide association studies (GWAS)—notably those conducted by large consortia such as the Psychiatric Genomics Consortium (PGC)—fundamentally reshaped understanding of ADHD genetics. These studies demonstrate that ADHD is not attributable to a single “ADHD gene,” but rather exhibits a highly polygenic architecture, in which hundreds to thousands of common genetic variants collectively contribute modest but additive effects [59]. Identified loci are enriched in genes expressed in the developing brain and involved in neurodevelopmental processes, reinforcing the biological foundations of the disorder [59]. In sum, genetic vulnerability constitutes the primary predictor of ADHD risk. However, it operates as a cumulative and probabilistic neurodevelopmental liability, which may remain latent or compensated until challenged by environmental or developmental stressors. This perspective explains both individual variability in symptom expression and the heterogeneity observed in clinical presentation. While genetics provides a foundation of vulnerability, environmental factors modulate the expression and timing of ADHD onset, particularly among individuals carrying elevated genetic risk. These influences occur across developmental windows. Prenatal and perinatal factors represent key environmental contributors. Maternal smoking [61] and alcohol exposure [62] during pregnancy are associated with increased ADHD risk, likely through neurotoxic effects on fetal development. Prematurity, low birth weight, and perinatal hypoxia have also been linked to subsequent ADHD, suggesting vulnerability due to subtle neural injury during critical periods of maturation [58]. Postnatal exposures include toxic and nutritional factors. Exposure to lead in childhood is associated with increased ADHD symptoms and executive dysfunction [63]. Nutritional insufficiencies, including low levels of omega-3 fatty acids and iron, have been implicated in symptom severity, though findings are less consistent [62]. The psychosocial environment plays a modulating role as well. Early adverse childhood experiences (ACEs), family conflict, low socioeconomic status, and neglect predict more severe ADHD trajectories and greater comorbidity (e.g., anxiety, oppositional symptoms) [64,65]. These exposures are best conceptualized not as primary causes of ADHD but as amplifiers of symptom burden among genetically susceptible individuals. A summary of key environmental risk domains and their putative neurodevelopmental mechanisms is presented in Figure 1. The convergence of genetic and environmental evidence supports a diathesis-stress model, indicating that neither genetic risk nor environmental exposure alone is sufficient to account for ADHD. Instead, gene-environment interactions (G×E) determine the likelihood, severity, and developmental timing of symptom expression [57]. Environmental influences exert differential effects depending on genotype, such that individuals with specific genetic profiles (e.g., variants in dopaminergic or serotonergic genes such as 5-HTTLPR) are more susceptible to the neurobehavioral impact of early adversity and psychosocial stress [57].
What the sources say
- Disputedcites [59] Demontis, 2019, Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder, Nat. Genet. sourceExperimental — accuracy not yet measured
The Results (Analysis of gene sets; page unavailable) report little evidence for effects in previously proposed ADHD candidate genes, with only SLC9A9 showing a weak association among the nine genes examined. The Discussion likewise says substantial effects were not observed in most previously reported candidate genes. The copy does not name DAT1/SLC6A3, DRD4, or the 7-repeat allele in these findings, so the contradiction is to the claim's broad assertion of repeated risk associations rather than a gene-specific result. (LLM, conf=0.73)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [60] Werling, 2019, Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder, J. Neural Transm. sourceExperimental — accuracy not yet measured
The Introduction and Results report associations between DAT1/SLC6A3 variants and ADHD, particularly the 10-repeat allele in children and adolescents, while noting small effects and heterogeneity. The paper does not report a repeated association between the DRD4 7-repeat allele and increased ADHD risk; DRD4 appears in reference titles, not in the paper’s findings. (LLM, conf=0.88)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“with PET studies showing increased microglial activation in adults with ADHD [85]”
§ ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives > 3. Etiology and Neurobiology of Adult ADHD > 3.5. Additional Neuroimaging Findings in ADHD Beyond structural and functional abnormalities identified in cortical and subcortical regions, recent large-scale and multimodal studies have provided additional insights into the neurobiology of ADHD. The ENIGMA-ADHD consortium, using voxel-based morphometry and analyses of cortical thickness, surface area, and volume, revealed reduced surface area in frontal regions, the cingulate gyrus, and temporal areas in children, whereas findings in adults have been more inconsistent, with some studies showing similar reductions and others reporting no significant group differences. Such variability likely reflects the influence of age-related neurodevelopmental trajectories, medication exposure, and the heterogeneity of ADHD across the lifespan [72]. Complementing these structural findings, diffusion tensor imaging (DTI) has highlighted alterations in white matter integrity, with reductions in fractional anisotropy observed across projection, commissural, and association pathways. These disruptions in structural connectivity correlate with symptom severity and cognitive deficits, suggesting that impaired communication between brain regions contributes to attentional and executive dysfunctions [83]. Moreover, electrophysiological studies employing electroencephalography (EEG) consistently report reduced P3 amplitudes during sustained attention tasks in adults with ADHD. The P3 component, an event-related potential reflecting attentional allocation and working memory processes, is diminished in ADHD, indicating difficulties in monitoring and sustaining attention [84]. Taken together, evidence from structural MRI, DTI, and EEG underscores that ADHD is characterized not only by cortical and subcortical abnormalities but also by widespread disruptions in structural connectivity and neurophysiological processing, reinforcing the view of ADHD as a disorder of distributed brain network dysfunction. In summary, the neurobiology of adult ADHD is best described as a disorder of distributed network integrity. It begins with a high polygenic diathesis, which, when coupled with environmental insults, perturbs the development of critical neurochemical systems, particularly the catecholaminergic modulation of fronto-striatal-cerebellar circuits. This leads to subtle but significant alterations in brain structure (e.g., smaller subcortical volumes, compromised white matter tracts). Ultimately, these structural and chemical abnormalities cascade into the functional domain, manifesting as a dynamic disconnection syndrome. The inefficient “switching” and coordination between the DMN, CEN, and SN result in an unstable cognitive state, impaired executive control, and the core clinical symptoms of the disorder. Emerging research is now probing novel etiological pathways. This includes the role of neuroinflammation, with PET studies showing increased microglial activation in adults with ADHD [85], and the microbiome-gut-brain axis, which may influence both neuroinflammation and neurotransmitter synthesis [86]. The notable neurobiological heterogeneity across individuals also suggests that adult ADHD is likely not a monolithic entity but a heterogeneous clinical syndrome with multiple, potentially overlapping, neurobiological subtypes.
What the sources say
- Disputedcites [85] Dunn, 2019, Neuroinflammation as a risk factor for attention deficit hyperactivity disorder, Pharmacol. Biochem. Behav. sourceExperimental — accuracy not yet measured
The Conclusion (page unavailable) describes PET imaging of activated microglia as a tool that will allow future studies to assess neuroinflammation in patients with ADHD. It does not report PET findings in adults with ADHD; the PET evidence it mentions concerns unspecified subjects and is described as preliminary. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In clinical and community samples of adults with ADHD, the combined presentation is by far the most common, accounting for roughly 63.5% of cases [89].”
§ ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives > 4. Neuropsychological Features of Adult ADHD: Comorbidity and Diagnostic Challenges > 4.1. Neuropsychological Perspective on Symptoms of Adult ADHD
What the sources say
- Disputedcites [89] Bedawi, R.M., Al-Farsi, Y., Mirza, H., Al-Huseini, S., Al-Mahrouqi, T., Al-Kiyumi, O., Al-Azri, M., and Al-Adawi, S. (2024). Prevalence and Clinical Profile of Adults with ADHD Attending a Tertiary Care Hospital for Five Years. Int. J. Environ. Res. Public Health, 21. sourceExperimental — accuracy not yet measured
The Results (§3.6; page not supplied) say that 63.5% of cases had the inattentive subtype, not the combined presentation. The Discussion (§4) likewise says inattention predominated in this Omani hospital cohort; the study does not establish that the combined presentation predominates across clinical and community samples. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
157 more claims · 84 with their cited sources checked
Create a free account to see all 293 claims and to verify the 7 references still open.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 119
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
ADHD Working Group of the Psychiatric Genomics Consortium (PGC), Demontis, D., Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium, 23andMe Research Team, Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., Baldursson, G., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0269-7 · Cited by 2,203 · cited 4×
“Variants within the dopamine transporter gene (DAT1/SLC6A3) and the dopamine D4 receptor gene (DRD4, especially the 7-repeat allele) were repeatedly associated with increased ADHD risk [59,60].”
InfluentialLai, M.-C., Kassee, C., Besney, R., Bonato, S., Hull, L., Mandy, W., Szatmari, P., & Ameis, S. H. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30289-5 · Cited by 1,892 · cited 1×
“Across studies, 15–50% of adults with ADHD exhibit autistic traits or meet ASD diagnostic thresholds, while 15–35% of adults with ASD also fulfill ADHD [42,43].”
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819 · cited 1×
“While this delay (e.g., in reaching peak cortical thickness) is prominent in children [73], findings in adults are more heterogeneous.”
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,716 · cited 1×
“Robust evidence supports the efficacy of stimulant medications (e.g., methylphenidate, amphetamines) and non-stimulants (e.g., atomoxetine) in reducing core symptoms of ADHD [142,143].”
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545 · cited 5×
“Prematurity, low birth weight, and perinatal hypoxia have also been linked to subsequent ADHD, suggesting vulnerability due to subtle neural injury during critical periods of maturation [58].”
InfluentialGenetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338 · cited 5×
“Instead, gene-environment interactions (G × E) determine the likelihood, severity, and developmental timing of symptom expression [57].”
InfluentialEmotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232 · cited 1×
“A recent systematic review estimates that emotional dysregulation is present in roughly 34–70% of adults with the disorder [103].”
Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies
Cortese, S., Kelly, C., Chabernaud, C., Proal, E., Di Martino, A., Milham, M. P., & Castellanos, F. X. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101521 · Cited by 1,067 · cited 1×
“At the same time, both functional and structural neuroimaging studies provide important insights into dysfunctions in brain networks involved in attention, impulsivity, and cognitive control—particularly within the prefrontal cortex, striatum, and limbic sys-tem [207].”
Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021) · Journal of Global Health · doi:10.7189/jogh.11.04009 · Cited by 896 · cited 2×
“Estimates suggest that adult ADHD affects between 3% and 6% of the population, underscoring the need for better diagnostic awareness and tailored treatment approaches in clinical practice [2–5].”
InfluentialMeta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder
Valera, E. M., Faraone, S. V., Murray, K. E., & Seidman, L. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.011 · Cited by 891
Hoogman, M., Bralten, J., Hibar, D. P., Mennes, M., Zwiers, M. P., Schweren, L. S. J., van Hulzen, K. J. E., Medland, S. E., Shumskaya, E., Jahanshad, N., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30049-4 · Cited by 879 · cited 1×
“Future research projects should emphasize long-term, multicenter prospective studies that allow for tracking neurobiological changes over time and their correlation with clinical symptoms and treatment response [208].”
Attention-deficit hyperactivity disorder
Posner, J., Polanczyk, G. V., & Sonuga-Barke, E. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33004-1 · Cited by 835 · cited 2×
“In adults (age ≥ 17), at least five symptoms in one domain are required for diagnosis (vs. six for children) [87,88].”
Large-scale brain systems in ADHD: beyond the prefrontal–striatal model
Castellanos, F. X., & Proal, E. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.007 · Cited by 831 · cited 1×
“Research has demonstrated hypoactivity and reduced connectivity within the CEN in adults with ADHD, which correlates with deficits in executive function-Int ing, cognitive flexibility, and goal-directed behavior [79].”
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · cited 3×
“Furthermore, this condition is associated with an elevated risk of comorbid psychiatric conditions, such as depression, anxiety, and substance use disorders, all of which complicate treatment and diminish quality of life [8,14].”
Practitioner Review: What have we learnt about the causes of ADHD?
Thapar, A., Cooper, M., Eyre, O., & Langley, K. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02611.x · Cited by 701 · cited 1×
“Future studies should investigate the impact of environmental toxin exposure, prenatal stress, nutritional deficiencies, and psychosocial factors on the development and progression of ADHD in adulthood [210].”
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686 · cited 1×
“While widely used, these methods often fail to capture the variability of symptom presentation in adults and the frequent presence of comorbid psychiatric conditions such as depression, anxiety disorders, or substance use disorders, which can complicate accurate diagnosis and treatment planning [4].”
Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02707-9 · Cited by 610 · cited 1×
“Emotional dysregulation and internalizing burden often require integrated management of ADHD and mood/anxiety symptoms [125], and addressing ADHD symptoms can itself mitigate secondary depression [141].”
Nakao, T., Radua, J., Rubia, K., & Mataix-Cols, D. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020281 · Cited by 588 · cited 1×
“While adults with ADHD show reduced fronto-striatal and cerebellar gray matter volume overall [127–130], these reductions appear more robust in males [131–133].”
Frodl, T., & Skokauskas, N. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01786.x · Cited by 530 · cited 1×
“While adults with ADHD show reduced fronto-striatal and cerebellar gray matter volume overall [127–130], these reductions appear more robust in males [131–133].”
Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091033 · Cited by 467 · cited 3×
“A follow-up ENIGMA study focusing on cortical metrics found that group differences were less pronounced in adults than in children [72].”
InfluentialThe Cerebellum and Neurodevelopmental Disorders
Stoodley, C. J. (2016) · The Cerebellum · doi:10.1007/s12311-015-0715-3 · Cited by 409 · cited 1×
“Literature data confirm smaller cerebellar volumes, supporting its role in the disorder’s pathophysiology [77].”
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180355 · Cited by 396 · cited 1×
“A systematic review by Catalá-López et al. [180] supports their efficacy in children, though evidence in adults remains less conclusive.”
van Ewijk, H., Heslenfeld, D. J., Zwiers, M. P., Buitelaar, J. K., & Oosterlaan, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.003 · Cited by 377 · cited 2×
“Across the literature, reduced fractional anisotropy (FA)—a hallmark of white-matter disruption—is repeatedly observed in major association and projection tracts [74,75].”
Hambleton, A., Pepin, G., Le, A., Maloney, D., National Eating Disorder Research Consortium, Aouad, P., Barakat, S., Boakes, R., Brennan, L., Bryant, E., et al. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00654-2 · Cited by 377 · cited 2×
“Evidence also links ADHD with binge-eating behaviors and bulimia, with a prevalence of 9–30% [109,110].”
Caye, A., Rocha, T. B.-M., Anselmi, L., Murray, J., Menezes, A. M. B., Barros, F. C., Gonçalves, H., Wehrmeister, F., Jensen, C. M., Steinhausen, H.-C., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0383 · Cited by 349
Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD
Wilens, T. E., Martelon, M., Joshi, G., Bateman, C., Fried, R., Petty, C., & Biederman, J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.01.021 · Cited by 339
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299 · cited 1×
“This includes the role of neuroinflammation, with PET studies showing increased microglial activation in adults with ADHD [85], and the microbiome-gut-brain axis, which may influence both neuroinflammation and neurotransmitter synthesis [86].”
Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01600 · Cited by 274 · cited 4×
“Many adults initially present for treatment of comorbid conditions, particularly depression, anxiety, or substance use disorders [117].”
InfluentialShining a light on CNTNAP2: Complex functions to complex disorders
Rodenas-Cuadrado, P., Ho, J., & Vernes, S. C. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.100 · Cited by 272 · cited 1×
“Neuroimaging and polygenic studies demonstrate shared alterations in fronto-striatal and default-mode networks, and overlapping risk loci such as FOXP1 and CNTNAP2 [45,46].”
Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis
Ellison-Wright, I., Ellison-Wright, Z., & Bullmore, E. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-51 · Cited by 269
Quinn, P. O., & Madhoo, M. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01596 · Cited by 264 · cited 1×
“In contrast, men demonstrate higher rates of substance use and externalizing behaviors [123,124].”
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261 · cited 1×
“By targeting maladaptive cognitions and behaviors, CBT enhances self-management, goal-setting, and time organization [160].”
Fusar-Poli, P., Rubia, K., Rossi, G., Sartori, G., & Balottin, U. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060940 · Cited by 260 · cited 1×
“This is supported by molecular imaging (PET/SPECT), which, despite some inconsistencies, meta-analytically points to increased DA transporter (DAT) density in the striatum [66].”
Basal Ganglia Volume and Shape in Children With Attention Deficit Hyperactivity Disorder
Qiu, A., Crocetti, D., Adler, M., Mahone, E. M., Denckla, M. B., Miller, M. I., & Mostofsky, S. H. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030426 · Cited by 253 · cited 1×
“While adults with ADHD show reduced fronto-striatal and cerebellar gray matter volume overall [127–130], these reductions appear more robust in males [131–133].”
Chen, Q., Hartman, C. A., Haavik, J., Harro, J., Klungsøyr, K., Hegvik, T.-A., Wanders, R., Ottosen, C., Dalsgaard, S., Faraone, S. V., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204516 · Cited by 236 · cited 1×
“Emerging evidence also suggests links between the condition in question and metabolic disorders, including obesity, pointing to complex neurobiological interactions between mental and physical health [15].”
Gamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
Instanes, J. T., Klungsøyr, K., Halmøy, A., Fasmer, O. B., & Haavik, J. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716669589 · Cited by 232 · cited 1×
“Mood disorders [51,52] and anxiety disorders [41] often exacerbate executive dysfunction associated with ADHD, while the symptoms of ADHD itself (e.g., mood lability, impulsivity) may be misdiagnosed as bipolar disorder or borderline personality disorder [55].”
Choi, W.-S., Woo, Y. S., Wang, S.-M., Lim, H. K., & Bahk, W.-M. (2022) · PLOS ONE · doi:10.1371/journal.pone.0277175 · Cited by 221 · cited 6×
“Personality disorders, particularly borderline and antisocial, frequently co-occur, with estimates suggesting up to 16–38% prevalence [107,111].”
InfluentialAmphetamines for attention deficit hyperactivity disorder (ADHD) in adults
Castells, X., Blanco-Silvente, L., & Cunill, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007813.pub3 · Cited by 209
Analyzing effective connectivity with functional magnetic resonance imaging
Stephan, K. E., & Friston, K. J. (2010) · WIREs Cognitive Science · doi:10.1002/wcs.58 · Cited by 202
van de Glind, G., Konstenius, M., Koeter, M. W. J., van Emmerik-van Oortmerssen, K., Carpentier, P.-J., Kaye, S., Degenhardt, L., Skutle, A., Franck, J., Bu, E.-T., et al. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.09.026 · Cited by 193 · cited 1×
“Differences in diagnostic criteria, such as DSM-IV, DSM-5, or ICD-10, as well as the assessment tools employed, ranging from self-report questionnaires to structured clinical interviews, substantially affect reported prevalence rates [16].”
Hirsch, O., Chavanon, M., Riechmann, E., & Christiansen, H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.007 · Cited by 190 · cited 1×
“In summary, adult ADHD typically involves not only inattention and behavioral impulsivity, but also pervasive difficulties in regulating emotions, even though the latter lie outside the formal DSM symptom criteria [105].”
van de Glind, G., van den Brink, W., Koeter, M. W. J., Carpentier, P.-J., van Emmerik-van Oortmerssen, K., Kaye, S., Skutle, A., Bu, E.-T. H., Franck, J., Konstenius, M., et al. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.010 · Cited by 189 · cited 1×
“The Adult ADHD Self-Report Scale (ASRS) and its short forms provide efficient identification of probable cases and demonstrate strong specificity and reliability (~0.90 Cronbach’s alpha) [31,118].”
InfluentialLundström, S., Chang, Z., Kerekes, N., Gumpert, C. H., Råstam, M., Gillberg, C., Lichtenstein, P., & Anckarsäter, H. (2011) · Psychological Medicine · doi:10.1017/s0033291711000377 · Cited by 174 · cited 1×
“Early adverse childhood experiences (ACEs), family conflict, low socioeconomic status, and neglect predict more severe ADHD trajectories and greater comorbidity (e.g., anxiety, oppositional symptoms) [64,65].”
Shanmugan, S., & Epperson, C. N. (2014) · Human Brain Mapping · doi:10.1002/hbm.22218 · Cited by 173 · cited 1×
“Moreover, fluctuations in ovarian hormones influence dopaminergic and noradrenergic signaling, with clinical reports describing symptom worsening during low-estrogen phases and across reproductive transitions [137–140].”
Distinguishing comorbidity and successful management of adult ADHD
Kooij, J. J. S., Huss, M., Asherson, P., Akehurst, R., Beusterien, K., French, A., Sasané, R., & Hodgkins, P. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711435361 · Cited by 172
Current Status of Cognitive Behavioral Therapy for Adult Attention-Deficit Hyperactivity Disorder
Knouse, L. E., & Safren, S. A. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.001 · Cited by 170 · cited 1×
“Concurrently, CBT (cognitive–behavioral therapy) has emerged as a valuable addition to adjuvant ADHD therapy, facilitating the development of compensatory strategies, improved self-management, and enhanced emotional regulation [144].”
Reduced white matter integrity in attention-deficit hyperactivity disorder
Hamilton, L. S., Levitt, J. G., O'Neill, J., Alger, J. R., Luders, E., Phillips, O. R., Caplan, R., Toga, A. W., McCracken, J., & Narr, K. L. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3283174415 · Cited by 167 · cited 1×
“Across the literature, reduced fractional anisotropy (FA)—a hallmark of white-matter disruption—is repeatedly observed in major association and projection tracts [74,75].”
Young, S., Hollingdale, J., Absoud, M., Bolton, P., Branney, P., Colley, W., Craze, E., Dave, M., Deeley, Q., Farrag, E., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01585-y · Cited by 162 · cited 3×
“This places ADHD among the most heritable psychiatric disorders, underscoring inherited neurobiological vulnerability as a central etiological component [50].”
Solberg, B. S., Halmøy, A., Engeland, A., Igland, J., Haavik, J., & Klungsøyr, K. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12845 · Cited by 157 · cited 1×
“In contrast, men demonstrate higher rates of substance use and externalizing behaviors [123,124].”
Structural and functional neuroimaging in attention-deficit/hyperactivity disorder
Albajara Sáenz, A., Villemonteix, T., & Massat, I. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14050 · Cited by 154 · cited 1×
“These disruptions in structural connectivity correlate with symptom severity and cognitive deficits, suggesting that impaired communication between brain regions contributes to attentional and executive dysfunctions [83].”
Occupational issues of adults with ADHD
Adamou, M., Arif, M., Asherson, P., Aw, T.-C., Bolea, B., Coghill, D., Guðjónsson, G., Halmøy, A., Hodgkins, P., Müller, U., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-59 · Cited by 152 · cited 2×
“Employees with ADHD consistently receive lower productivity ratings, exhibit higher absenteeism, and demonstrate shorter job tenure [10,194].”
InfluentialEvidence of emotion dysregulation as a core symptom of adult ADHD: A systematic review
Soler-Gutiérrez, A.-M., Pérez-González, J.-C., & Mayas, J. (2023) · PLOS ONE · doi:10.1371/journal.pone.0280131 · Cited by 152 · cited 2×
“Never-theless, consensus among clinicians and researchers is that emotion regulation problems and impulsive emotional reactions are extremely common in adults with this disorder [104].”
Oades, R. D., Dauvermann, M. R., Schimmelmann, B. G., Schwarz, M. J., & Myint, A.-M. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-29 · Cited by 151
Pharmacological and non-pharmacological treatment of adults with ADHD: A meta-review
De Crescenzo, F., Cortese, S., Adamo, N., & Janiri, L. (2017) · Evidence Based Mental Health · doi:10.1136/eb-2016-102415 · Cited by 150
Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome
Caye, A., Swanson, J., Thapar, A., Sibley, M., Arseneault, L., Hechtman, L., Arnold, L. E., Niclasen, J., Moffitt, T., & Rohde, L. A. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0750-x · Cited by 145
Faraone, S. V., Spencer, T. J., Montano, C. B., & Biederman, J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.11.1221 · Cited by 144 · cited 1×
“Reviews of clinical records indicate even higher rates: in one study of psychiatric and primary care patients in the USA, only 25% had a childhood diagnosis, suggesting that ~75% received their first diagnosis as adults [36].”
The impacts associated with having ADHD: an umbrella review
French, B., Nalbant, G., Wright, H., Sayal, K., Daley, D., Groom, M. J., Cassidy, S., & Hall, C. L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1343314 · Cited by 144 · cited 2×
“Numerous reviews and large-scale cohort studies demonstrate persistent educational underachieve-ment, including lower rates of high school and college completion and reduced attainment of advanced degrees compared with controls [191,192].”
Mostert, J. C., Onnink, A. M. H., Klein, M., Dammers, J., Harneit, A., Schulten, T., van Hulzen, K. J. E., Kan, C. C., Slaats-Willemse, D., Buitelaar, J. K., et al. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.010 · Cited by 142 · cited 7×
“Thus, while planning/organization problems, working memory deficits, inflexibility, and poor impulse control are commonly observed in adult ADHD, the severity of these deficits can differ greatly among patients [92,94].”
InfluentialPettersson, R., Söderström, S., & Nilsson, K. W. (2018) · Journal of Attention Disorders · doi:10.1177/1087054715618788 · Cited by 141
Cherkasova, M. V., Roy, A., Molina, B. S. G., Scott, G., Weiss, G., Barkley, R. A., Biederman, J., Uchida, M., Hinshaw, S. P., Owens, E. B., et al. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.05.019 · Cited by 137 · cited 2×
“Numerous reviews and large-scale cohort studies demonstrate persistent educational underachieve-ment, including lower rates of high school and college completion and reduced attainment of advanced degrees compared with controls [191,192].”
Renoux, C., Shin, J., Dell'Aniello, S., Fergusson, E., & Suissa, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13000 · Cited by 132 · cited 1×
“In turn, B vitamins—including B6, B12, and folate—play critical roles in neurotransmitter synthesis, but their specific effects on ADHD in adults remain unclear [184].”
Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression
Onnink, A. M. H., Zwiers, M. P., Hoogman, M., Mostert, J. C., Kan, C. C., Buitelaar, J., & Franke, B. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.011 · Cited by 131
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
Li, L., Zhu, N., Zhang, L., Kuja-Halkola, R., D’Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z. (2024) · JAMA · doi:10.1001/jama.2024.0851 · Cited by 124 · cited 1×
“These diets aim to reduce systemic inflammation and identify food-based symptom triggers [185].”
Ebejer, J. L., Medland, S. E., van der Werf, J., Gondro, C., Henders, A. K., Lynskey, M., Martin, N. G., & Duffy, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047404 · Cited by 117
Parental ADHD Symptomology and Ineffective Parenting: The Connecting Link of Home Chaos
Mokrova, I., O'Brien, M., Calkins, S., & Keane, S. (2010) · Parenting · doi:10.1080/15295190903212844 · Cited by 117 · cited 4×
“When both partners have ADHD, these effects are magnified, leading to especially high rates of discord and negative conflict styles [201,203].”
InfluentialHarikumar, A., Evans, D. W., Dougherty, C. C., Carpenter, K. L. H., & Michael, A. M. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0865 · Cited by 113
Brevik, E. J., Lundervold, A. J., Haavik, J., & Posserud, M. (2020) · Brain and Behavior · doi:10.1002/brb3.1605 · Cited by 111 · cited 1×
“Structured diagnostic interviews, particularly the DIVA-5, enhance diagnostic precision by systematically assessing developmental history and functional impairment across life domains [119,120].”
ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning
Fuermaier, A. B. M., Tucha, L., Butzbach, M., Weisbrod, M., Aschenbrenner, S., & Tucha, O. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02309-z · Cited by 103 · cited 2×
“Emotional impulsivity and low frustration tolerance can precipitate interpersonal conflict, while inattention may be misinterpreted as disinterest or irresponsibility [10,97,198].”
Lin, H.-Y., Tseng, W.-Y. I., Lai, M.-C., Matsuo, K., & Gau, S. S.-F. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771500020x · Cited by 102
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study
Brod, M., Pohlman, B., Lasser, R., & Hodgkins, P. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-47 · Cited by 102 · cited 1×
“These symptoms, being more “visible” to clinicians, can obscure underlying ADHD or lead to misdiagnosis (e.g., solely depression or anxiety disorders) [19,38,39].”
Working memory and short-term memory deficits in ADHD: A bifactor modeling approach
Kofler, M. J., Singh, L. J., Soto, E. F., Chan, E. S. M., Miller, C. E., Harmon, S. L., & Spiegel, J. A. (2020) · Neuropsychology · doi:10.1037/neu0000641 · Cited by 101 · cited 1×
“[56] Autism Spectrum Disorder (ASD) 15–50% Reflects shared neurodevelopmental and genetic origins; leads to compounded functional impairment and emotional dysregulation.”
Meta-analysis of cognitive-behavioral treatments for adult ADHD
Knouse, L. E., Teller, J., & Brooks, M. A. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000216 · Cited by 101
Todd, R. D., & Neuman, R. J. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30640 · Cited by 99 · cited 1×
“Early adverse childhood experiences (ACEs), family conflict, low socioeconomic status, and neglect predict more severe ADHD trajectories and greater comorbidity (e.g., anxiety, oppositional symptoms) [64,65].”
Staley, B. S., Robinson, L. R., Claussen, A. H., Katz, S. M., Danielson, M. L., Summers, A. D., Farr, S. L., Blumberg, S. J., & Tinker, S. C. (2024) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7340a1 · Cited by 93
An Empirical Evaluation of ADHD Coaching in College Students
Prevatt, F., & Yelland, S. (2015) · Journal of Attention Disorders · doi:10.1177/1087054713480036 · Cited by 91 · cited 1×
“Schema Therapy (ST) addresses deeply rooted maladaptive schemas related to chronic failure, inadequacy, and rejection, which are prevalent in adults with ADHD [162,163].”
Waxmonsky, J. G., Waschbusch, D. A., Belin, P., Li, T., Babocsai, L., Humphery, H., Pariseau, M. E., Babinski, D. E., Hoffman, M. T., Haak, J. L., et al. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.12.011 · Cited by 87 · cited 1×
“Coaching interventions emphasize structured goal-setting, accountability, and reinforcement of adaptive routines [165].”
Al-Wardat, M. S., Etoom, M., Almhdawi, K. A., Hawamdeh, Z. M., & Khader, Y. S. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078849 · Cited by 80
Reproductive steroids and ADHD symptoms across the menstrual cycle
Roberts, B., Eisenlohr-Moul, T., & Martel, M. M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.015 · Cited by 77
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
Bozzatello, P., Rocca, P., Mantelli, E., & Bellino, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215257 · Cited by 73 · cited 1×
“Tailoring strategies based on the patient’s dietary habits, nutritional status, and clinical profile is essential for optimizing outcomes [188].”
Green, J. G., DeYoung, G., Wogan, M. E., Wolf, E. J., Lane, K. L., & Adler, L. A. (2019) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1751 · Cited by 70
Rosch, K. S., Mostofsky, S. H., & Nebel, M. B. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-018-9254-9 · Cited by 69 · cited 1×
“Functional imaging similarly points to sex-differentiated profiles: men typically exhibit reduced activation in executive networks, whereas women often display activation closer to neurotypical controls—potentially reflecting compensatory neural recruitment [135].”
Mao, A. R., & Findling, R. L. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2799 · Cited by 68 · cited 2×
“Up to 50–80% of adults with ADHD meet criteria for at least one other psychiatric disorder [40,41] (Table 3).”
Ginapp, C. M., Greenberg, N. R., Macdonald-Gagnon, G., Angarita, G. A., Bold, K. W., & Potenza, M. N. (2023) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2023.100223 · Cited by 67 · cited 3×
“Family systems are similarly affected: adults with ADHD frequently struggle to meet domestic obligations such as managing finances or maintaining household organization, contributing to family chaos and stress [202,203].”
Efficacy of ADHD coaching for adults with ADHD
Kubik, J. A. (2010) · Journal of Attention Disorders · doi:10.1177/1087054708329960 · Cited by 67 · cited 1×
“Evidence suggests that structured coaching programs can significantly improve goal attainment, organization, and functional outcomes [200].”
Eating Patterns and Dietary Interventions in ADHD: A Narrative Review
Pinto, S., Correia-de-Sá, T., Sampaio-Maia, B., Vasconcelos, C., Moreira, P., & Ferreira-Gomes, J. (2022) · Nutrients · doi:10.3390/nu14204332 · Cited by 66 · cited 1×
“These nutrients support neuronal membrane fluidity and synaptic plasticity, both crucial for cognitive control and attention regulation [179].”
Yoshimasu, K., Barbaresi, W. J., Colligan, R. C., Voigt, R. G., Killian, J. M., Weaver, A. L., & Katusic, S. K. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716676342 · Cited by 65 · cited 1×
“Mood disorders [51,52] and anxiety disorders [41] often exacerbate executive dysfunction associated with ADHD, while the symptoms of ADHD itself (e.g., mood lability, impulsivity) may be misdiagnosed as bipolar disorder or borderline personality disorder [55].”
Santosh, P. J., Sattar, S., & Canagaratnam, M. (2011) · CNS Drugs · doi:10.2165/11593070-000000000-00000 · Cited by 62 · cited 1×
“Current guidelines, including NICE NG87, advocate a multimodal approach in which stimulant pharmacotherapy is complemented by psychoeducation, cognitive–behavioral interventions, and skills-based training [116,152].”
Van Dessel, J., Sonuga‐Barke, E., Mies, G., Lemiere, J., Van der Oord, S., Morsink, S., & Danckaerts, M. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12868 · Cited by 61 · cited 1×
“Concurrently, dysregulation in the mesolimbic pathway is linked to altered reward processing and the “delay aversion” characteristic of ADHD [68].”
Are negative automatic thoughts associated with ADHD in adulthood?
Mitchell, J. T., Benson, J. W., Knouse, L. E., Kimbrel, N. A., & Anastopoulos, A. D. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-013-9525-4 · Cited by 61 · cited 1×
“…these cognitive–emotional patterns, ST can reduce chronic shame and improve relational functioning—areas often resistant to conventional CBT. Social Skills Training (SST) specifically targets interpersonal communication and behavioral self-regulation through modeling and feedback [164].”
Senkowski, D., Ziegler, T., Singh, M., Heinz, A., He, J., Silk, T., & Lorenz, R. C. (2024) · Neuropsychology Review · doi:10.1007/s11065-023-09592-5 · Cited by 59 · cited 3×
“The clinical relevance of these deficits is high; adults exhibiting multiple EF impairments often report greater academic and occupational difficulties [93,97].”
Planning ability in adults with attention-deficit/hyperactivity disorder
Young, S., Morris, R., Toone, B., & Tyson, C. (2007) · Neuropsychology · doi:10.1037/0894-4105.21.5.581 · Cited by 58 · cited 1×
“Executive dysfunction, particularly deficits in working memory, planning, and cognitive flexibility, emerges as a central explanatory factor [10,196,197].”
Prevalence and Correlates of Self-Reported ADD/ADHD in a Large National Sample of Canadian Adults
Hesson, J., & Fowler, K. (2018) · Journal of Attention Disorders · doi:10.1177/1087054715573992 · Cited by 56 · cited 1×
“Up to 50–80% of adults with ADHD meet criteria for at least one other psychiatric disorder [40,41] (Table 3).”
A Review of Canadian Diagnosed ADHD Prevalence and Incidence Estimates Published in the Past Decade
Espinet, S. D., Graziosi, G., Toplak, M. E., Hesson, J., & Minhas, P. (2022) · Brain Sciences · doi:10.3390/brainsci12081051 · Cited by 56
Surman, C. B. H., Monuteaux, M. C., Petty, C. R., Faraone, S. V., Spencer, T. J., Chu, N. F., & Biederman, J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05344pur · Cited by 54
Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1597559 · Cited by 54 · cited 6×
“Notably, many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112].”
InfluentialLin, Y.-J., Yang, L.-K., & Gau, S. S.-F. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415609423 · Cited by 52
Salomone, S., Fleming, G. R., Bramham, J., O’Connell, R. G., & Robertson, I. H. (2020) · Journal of Attention Disorders · doi:10.1177/1087054715623045 · Cited by 49 · cited 1×
“The P3 component, an event-related potential reflecting attentional allocation and working memory processes, is diminished in ADHD, indicating difficulties in monitoring and sustaining attention [84].”
López-Pinar, C., Martínez-Sanchís, S., Carbonell-Vayá, E., Sánchez-Meca, J., & Fenollar-Cortés, J. (2020) · Journal of Attention Disorders · doi:10.1177/1087054719855685 · Cited by 47 · cited 1×
“This understanding fosters self-advocacy, treatment adherence, and reduced stigma [166].”
Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
Barbuti, M., Maiello, M., Spera, V., Pallucchini, A., Brancati, G., Maremmani, A., Perugi, G., & Maremmani, I. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093096 · Cited by 47 · cited 1×
“Treatment of ADHD—particularly with stimulants or atomoxetine—may attenuate depressive symptoms and reduce relapse risk in mood and anxiety disorders [113].”
Mattos, P., Louzã, M. R., Palmini, A. L. F., Oliveira, I. R. D., & Rocha, F. L. (2013) · Journal of Attention Disorders · doi:10.1177/1087054711434772 · Cited by 47 · cited 1×
“These symptoms, being more “visible” to clinicians, can obscure underlying ADHD or lead to misdiagnosis (e.g., solely depression or anxiety disorders) [19,38,39].”
Females With ADHD Report More Severe Symptoms Than Males on the Adult ADHD Self-Report Scale
Vildalen, V. U., Brevik, E. J., Haavik, J., & Lundervold, A. J. (2019) · Journal of Attention Disorders · doi:10.1177/1087054716659362 · Cited by 47 · cited 4×
“Delayed identification in women is associated with prolonged functional impairment, lower self-esteem, and greater psychiatric comorbidity [125].”
InfluentialHolst, Y., & Thorell, L. B. (2017) · Journal of Attention Disorders · doi:10.1177/1087054713506264 · Cited by 46
Gordon, H. A., Rucklidge, J. J., Blampied, N. M., & Johnstone, J. M. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0105 · Cited by 45 · cited 1×
“Ongoing monitoring of symptoms and nutritional parameters allows for the adaptation of dietary strategies over time, improving both effectiveness and patient engagement [190].”
Neuropsychological Performance Patterns of Adult ADHD Subtypes
LeRoy, A., Jacova, C., & Young, C. (2019) · Journal of Attention Disorders · doi:10.1177/1087054718773927 · Cited by 45
Stress and work-related mental illness among working adults with ADHD: a qualitative study
Oscarsson, M., Nelson, M., Rozental, A., Ginsberg, Y., Carlbring, P., & Jönsson, F. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04409-w · Cited by 45 · cited 1×
“Qualitative studies highlight the use of compensatory strategies such as external structuring systems (e.g., digital calendars, multiple alarms, and task-specific reminders) and behavioral techniques like stimulus control or task segmentation [199].”
Villemonteix, T., Brito, S. A. D., Kavec, M., Balériaux, D. F., Metens, T., Slama, H., Baijot, S., Mary, A., Peigneux, P., & Massat, I. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.015 · Cited by 45 · cited 1×
“While adults with ADHD show reduced fronto-striatal and cerebellar gray matter volume overall [127–130], these reductions appear more robust in males [131–133].”
Haimov-Kochman, R., & Berger, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00191 · Cited by 40
Vitamin levels in adults with ADHD
Landaas, E. T., Aarsland, T. I. M., Ulvik, A., Halmøy, A., Ueland, P. M., & Haavik, J. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.116.003491 · Cited by 39 · cited 1×
“Multidisciplinary collaboration, involving healthcare providers such as dietitians and mental health professionals, enhances intervention design and adherence [189].”
Female-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage
de Jong, M., Wynchank, D. S. M. R., van Andel, E., Beekman, A. T. F., & Kooij, J. J. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1306194 · Cited by 39 · cited 3×
“Moreover, fluctuations in ovarian hormones influence dopaminergic and noradrenergic signaling, with clinical reports describing symptom worsening during low-estrogen phases and across reproductive transitions [137–140].”
Grünblatt, E., Werling, A. M., Roth, A., Romanos, M., & Walitza, S. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01998-x · Cited by 39 · cited 1×
“Variants within the dopamine transporter gene (DAT1/SLC6A3) and the dopamine D4 receptor gene (DRD4, especially the 7-repeat allele) were repeatedly associated with increased ADHD risk [59,60].”
Wang, C. H., Mazursky-Horowitz, H., & Chronis-Tuscano, A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0474-8 · Cited by 39 · cited 1×
“CBT is the most extensively validated modality for adult ADHD, demonstrating moderate-to-large effects on symptom reduction and comorbid anxiety and depression [159].”
Geographical variation in ADHD: Do diagnoses reflect symptom levels?
Widding-Havneraas, T., Markussen, S., Elwert, F., Lyhmann, I., Bjelland, I., Halmøy, A., Chaulagain, A., Ystrom, E., Mykletun, A., & Zachrisson, H. D. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-01996-7 · Cited by 39 · cited 1×
“Regional and cultural variations, differing mental health awareness, healthcare access, and social stigma further modulate reported prevalence rates [20–22].”
Vingilis, E., Erickson, P. G., Toplak, M. E., Kolla, N. J., Mann, R. E., Seeley, J., vanderMaas, M., & Daigle, D. S. (2015) · BioMed Research International · doi:10.1155/2015/982072 · Cited by 37
Neuropsychological functioning of individuals at clinical evaluation of adult ADHD
Guo, N., Fuermaier, A. B. M., Koerts, J., Mueller, B. W., Diers, K., Mroß, A., Mette, C., Tucha, L., & Tucha, O. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02281-0 · Cited by 37 · cited 4×
“For example, deficits in basic processing speed and focused attention explain a large share of the variance in complex EF tasks [98].”
InfluentialMorkem, R., Handelman, K., Queenan, J. A., Birtwhistle, R., & Barber, D. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01182-2 · Cited by 37
Lauder, K., McDowall, A., & Tenenbaum, H. R. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.893469 · Cited by 36 · cited 1×
“Moreover, the complexity of contemporary work environments characterized by multitasking demands and frequent distractions poses additional challenges for adults managing these symptoms [10,11].”
Assessing adult ADHD: New research and perspectives
Lovett, B. J., & Harrison, A. G. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.1950640 · Cited by 35 · cited 3×
“While collateral information, such as parent reports and school records, enhances validity [117,121], such data are frequently unavailable in routine care.”
Leaberry, K. D., Rosen, P. J., Fogleman, N. D., Walerius, D. M., & Slaughter, K. E. (2020) · Journal of Attention Disorders · doi:10.1177/1087054717734647 · Cited by 35 · cited 1×
“Dialectical Behavior Therapy (DBT) extends this approach to the domain of emotional dysregulation, emphasizing mindfulness, distress tolerance, and interpersonal effectiveness [161].”
Ben-Dor Cohen, M., Eldar, E., Maeir, A., & Nahum, M. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01904-8 · Cited by 35 · cited 2×
“These symptoms, being more “visible” to clinicians, can obscure underlying ADHD or lead to misdiagnosis (e.g., solely depression or anxiety disorders) [19,38,39].”
Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD
Slobodin, O., & Crunelle, C. L. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00173 · Cited by 35
Unraveling the spectrum: overlap, distinctions, and nuances of ADHD and ASD in children
Martinez, S., Stoyanov, K., & Carcache, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1387179 · Cited by 33 · cited 1×
“This substantial overlap supports the view that ADHD and ASD exist along a shared neurodevelopmental spectrum, characterized by convergent deficits in executive control, attention regulation, and social cognition [44].”
Véronneau-Veilleux, F., Robaey, P., Ursino, M., & Nekka, F. (2022) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2022.849323 · Cited by 32 · cited 1×
“This, in turn, results in attenuated phasic (task-related) DA firing in response to salient stimuli, leading to a weakened “signal-to-noise” ratio in the PFC [67].”
Yue, X., Liu, L., Chen, W., Preece, D. A., Liu, Q., Li, H., Wang, Y., & Qian, Q. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.065 · Cited by 32
Hilger, K., & Fiebach, C. J. (2019) · Network Neuroscience · doi:10.1162/netn_a_00083 · Cited by 31 · cited 2×
“A meta-analysis identified consistent alterations in connectivity between the DMN and CEN in adults with the disorder, which correlate with attentional deficits and impaired cognitive control [78].”
Kenter, R. M. F., Gjestad, R., Lundervold, A. J., & Nordgreen, T. (2023) · Internet Interventions · doi:10.1016/j.invent.2023.100614 · Cited by 30 · cited 1×
“Its anti-inflammatory properties may explain observed reductions in ADHD symptoms [186].”
Vidor, M. V., Panzenhagen, A. C., Martins, A. R., Cupertino, R. B., Bandeira, C. E., Picon, F. A., da Silva, B. S., Vitola, E. S., Rohde, L. A., Rovaris, D. L., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01397-6 · Cited by 29 · cited 1×
“Given that glutamate signaling is tightly coupled with and modulates DA release, this suggests that fronto-striatal dysfunction in ADHD may be a product of imbalanced glutamate/GABA-DA interactions [70].”
Executive function deficits mediate the relationship between employees’ ADHD and job burnout
Turjeman-Levi, Y., Itzchakov, G., & Engel-Yeger, B. (2024) · AIMS Public Health · doi:10.3934/publichealth.2024015 · Cited by 28 · cited 6×
“These patterns are empirically supported: workplace studies show that impairments in time management and self-organization mediate the link between ADHD symptoms and job burnout, suggesting that executive dysfunction operates as a proximal driver of occupational underperformance [10,97,198].”
InfluentialAhlberg, R., Du Rietz, E., Ahnemark, E., Andersson, L. M., Werner-Kiechle, T., Lichtenstein, P., Larsson, H., & Garcia-Argibay, M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04713-z · Cited by 27 · cited 4×
“Collectively, these data underscore that ADHD in adulthood is not simply a residual childhood condition but a major determinant of lower educational attainment, unstable employment, and diminished productivity [192,195].”
InfluentialKhoshbakht, Y., Moghtaderi, F., Bidaki, R., Hosseinzadeh, M., & Salehi-Abargouei, A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02527-x · Cited by 27 · cited 1×
“Iron, particularly low ferritin levels, has been associated with reduced dopaminergic activity; supplementation may improve concentration and executive functioning in those with iron deficiency [183].”
Sasayama, D., Kuge, R., Toibana, Y., & Honda, H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.34179 · Cited by 26 · cited 2×
“National insurance claims (N = 838,265 new ADHD) ≥ 20 years 40% of all new ADHD cases were in adults [37] Global statistics and data on late diagnosis also mask significant demographic issues, the most important of which is the systemic underdiagnosis of women.”
Validity of the Korean Version of DIVA-5: A Semi-Structured Diagnostic Interview for Adult ADHD
Hong, M., Kooij, J. S., Kim, B., Joung, Y.-S., Yoo, H. K., Kim, E.-J., Lee, S. I., Bhang, S.-Y., Lee, S. Y., Han, D. H., et al. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s262995 · Cited by 25 · cited 1×
“Structured diagnostic interviews, particularly the DIVA-5, enhance diagnostic precision by systematically assessing developmental history and functional impairment across life domains [119,120].”
Pelsser, L., Frankena, K., Toorman, J., & Rodrigues Pereira, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00096 · Cited by 25 · cited 3×
“Magnesium has shown promise in reducing hyperactivity and inat-tention in children, but adult data are limited [182].”
InfluentialLewis, N., Villani, A., & Lagopoulos, J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.031 · Cited by 25 · cited 1×
“This includes the role of neuroinflammation, with PET studies showing increased microglial activation in adults with ADHD [85], and the microbiome-gut-brain axis, which may influence both neuroinflammation and neurotransmitter synthesis [86].”
Sánchez‐Mora, C., Richarte, V., Garcia‐Martínez, I., Pagerols, M., Corrales, M., Bosch, R., Vidal, R., Viladevall, L., Casas, M., Cormand, B., et al. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32340 · Cited by 23 · cited 1×
“Exposure to lead in childhood is associated with increased ADHD symptoms and executive dysfunction [63].”
Breda, V., Rovaris, D. L., Vitola, E. S., Mota, N. R., Blaya-Rocha, P., Salgado, C. A. I., Victor, M. M., Picon, F. A., Karam, R. G., Silva, K. L., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415609421 · Cited by 22 · cited 1×
“Studies indicate that around 60–65% of individuals diagnosed in childhood continue to experience this condition’s symptoms as adults [6,7].”
Deserno, M. K., Bathelt, J., Groenman, A. P., & Geurts, H. M. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-01986-9 · Cited by 22 · cited 1×
“The current evidence base supports conceptualizing ADHD–ASD overlap as a distinct hybrid phenotype rather than a mere comorbidity [48–50].”
Al-Yateem, N., Slewa-Younan, S., Halimi, A., Saeed, S. A., Tliti, D., Mohammad, M., Ridwan, M., Zeidan, R., Hammash, M. H., Ahmed, F. R., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00167-4 · Cited by 22 · cited 2×
“Estimates suggest that adult ADHD affects between 3% and 6% of the population, underscoring the need for better diagnostic awareness and tailored treatment approaches in clinical practice [2–5].”
InfluentialYerys, B. E., McQuaid, G. A., Lee, N. R., & Wallace, G. L. (2022) · Autism · doi:10.1177/13623613221112198 · Cited by 21 · cited 1×
“Functionally, adults with co-occurring ADHD– ASD show additive impairments—lower quality of life, greater emotional dysregulation, and poorer occupational and social outcomes than either disorder alone [47].”
Adult attention deficit hyperactivity disorder and early maladaptive schemas
Kiraz, S., & Sertçelik, S. (2021) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2569 · Cited by 20 · cited 1×
“Regular feedback loops between coach and client reinforce accountability, enhance executive functioning, and sustain behavioral change [170].”
Taylor, M. J., Larsson, H., Gillberg, C., Lichtenstein, P., & Lundström, S. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12988 · Cited by 20
Being different but striving to seem normal: The lived experiences of people aged 50+ with ADHD
Nyström, A., Petersson, K., & Janlöv, A.-C. (2020) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1695029 · Cited by 19 · cited 1×
“Evidence indicates that understanding, structured, and nonjudgmental relationships enhance coping and reduce functional impairment [202,205].”
Oguchi, M., Takahashi, T., Nitta, Y., & Kumano, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.708579 · Cited by 18 · cited 1×
“Individuals with ADHD also show higher rates of relationship dissolution and tendencies toward social isolation, often due to difficulties interpreting social cues [12,13].”
Attention deficit hyperactivity disorder in adults: What the non-specialist needs to know
Johnson, J., Morris, S., & George, S. (2020) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.0188 · Cited by 18
Young, S., Morris, R., Toone, B., & Tyson, C. (2006) · Personality and Individual Differences · doi:10.1016/j.paid.2006.03.005 · Cited by 18 · cited 1×
“Executive dysfunction, particularly deficits in working memory, planning, and cognitive flexibility, emerges as a central explanatory factor [10,196,197].”
In de Braek, D., Dijkstra, J. B., & Jolles, J. (2011) · Applied Neuropsychology · doi:10.1080/09084282.2011.570614 · Cited by 18 · cited 1×
“Effect sizes for comparisons were mostly small, and neuropsychological tests showed limited power to distinguish ADHD from other psychiatric referrals [99–102].”
Alarachi, A., Merrifield, C., Rowa, K., & McCabe, R. E. (2024) · Assessment · doi:10.1177/10731911231225190 · Cited by 17 · cited 1×
“Notably, many individuals treated exclusively for depression or anxiety continue to experience disabling attentional symptoms, delaying recovery [106,112].”
Soares, L. S., Alves, A. L. C., Costa, D. D. S., Malloy-Diniz, L. F., Paula, J. J. D., Romano-Silva, M. A., & Miranda, D. M. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.593150 · Cited by 17 · cited 1×
“Individuals with ADHD also show higher rates of relationship dissolution and tendencies toward social isolation, often due to difficulties interpreting social cues [12,13].”
Kawabe, K., Horiuchi, F., Matsumoto, Y., Inoue, S., Okazawa, M., Hosokawa, R., Nakachi, K., Soga, J., & Ueno, S. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12381 · Cited by 17 · cited 3×
“Atomoxetine consistently yields moderate symptom reduction across age groups [157], while guanfacine improves attention and behavioral regulation in adults with emotional dysregulation [154,155].”
ADHD in Adults: Does Age at Diagnosis Matter?
Hutt Vater, C., DiSalvo, M., Ehrlich, A., Parker, H., O’Connor, H., Faraone, S. V., & Biederman, J. (2024) · Journal of Attention Disorders · doi:10.1177/10870547231218450 · Cited by 17 · cited 1×
“Additionally, study design elements, including cross-sectional versus longitudinal methodologies, influence the interpretation of ADHD prevalence by either capturing a snapshot or longitudinal persistence of symptoms [23].”
Let’s Talk about Sex… and ADHD: Findings from an Anonymous Online Survey
Young, S., Klassen, L. J., Reitmeier, S. D., Matheson, J. D., & Gudjonsson, G. H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032037 · Cited by 17 · cited 1×
“Adults with ADHD report lower sexual satisfaction and overall relationship fulfillment compared to controls [206], with partners of individuals with ADHD describing similar dissatisfaction.”
Psychosocial therapeutic approaches for high-functioning autistic adults
Schweizer, T., Endres, D., Dziobek, I., & Tebartz van Elst, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1265066 · Cited by 16
Sex differences in adults with attention-deficit/hyperactivity disorder: A population-based study
Mestres, F., Richarte, V., Crespín, J. J., Torrent, C., Biel, S., Ramos, C., Ibáñez, P., Oltra-Arañó, L., Corrales, M., Amoretti, S., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.2441 · Cited by 16 · cited 3×
“Women also report greater global symptom severity and markedly higher rates of internalizing comorbidities, particularly depression and anxiety [122].”
Influential‘Hey, look at me’: An {auto}ethnographic account of experiencing ADHD symptoms within sport
Ing, C., & Mills, J. P. (2019) · Qualitative Research in Sport, Exercise and Health · doi:10.1080/2159676x.2017.1405362 · Cited by 15 · cited 1×
“Schema Therapy (ST) addresses deeply rooted maladaptive schemas related to chronic failure, inadequacy, and rejection, which are prevalent in adults with ADHD [162,163].”
Weibel, S., Bicego, F., Muller, S., Martz, E., Costache, M. E., Kraemer, C., Bertschy, G., Lopez, R., & Weiner, L. (2022) · Journal of Attention Disorders · doi:10.1177/10870547211027647 · Cited by 14 · cited 1×
“Furthermore, the nature of the study population plays a crucial role; clinical samples or individuals seeking psychiatric care generally exhibit higher ADHD rates than community-based samples, reflecting selection bias [17,18].”
Okada, T., Sotodate, T., Ogasawara-Shimizu, M., & Nishigaki, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1359872 · Cited by 14 · cited 2×
“[55]”
Kao, P.-H., Ho, C.-H., & Huang, C. L.-C. (2025) · PLOS ONE · doi:10.1371/journal.pone.0315587 · Cited by 13 · cited 2×
“These divergent trajectories shape clinical engagement: women frequently enter care through mood or anxiety pathways, whereas men are more often referred due to behavioral or substance-related difficulties [125,126].”
Wietecha, L. A., Clemow, D. B., Buchanan, A. S., Young, J. L., Sarkis, E. H., & Findling, R. L. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12533 · Cited by 13
Dupont, G., van Rooij, D., Buitelaar, J. K., Reif, A., & Grimm, O. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.962911 · Cited by 12 · cited 2×
“Women demonstrate more variable patterns, with relatively preserved fronto-striatal volume but more frequent alterations in limbic and parietal circuitry linked to emotional and attentional regulation [134].”
Jakobsson Støre, S., Van Zalk, N., Granander Schwartz, W., Nilsson, V., & Tillfors, M. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241247448 · Cited by 12 · cited 1×
“Social anxiety, affecting up to half of adults with ADHD [204], frequently co-occurs and exacerbates avoidance behaviors, reinforcing isolation and impairing the formation of supportive networks.”
Stickley, A., Leinsalu, M., Ruchkin, V., Oh, H., Narita, Z., & Koyanagi, A. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.12.004 · Cited by 11 · cited 1×
“Regional and cultural variations, differing mental health awareness, healthcare access, and social stigma further modulate reported prevalence rates [20–22].”
Acosta, H., Kantojärvi, K., Tuulari, J. J., Lewis, J. D., Hashempour, N., Scheinin, N. M., Lehtola, S. J., Nolvi, S., Fonov, V. S., Collins, D. L., et al. (2024) · Development and Psychopathology · doi:10.1017/s0954579423000275 · Cited by 11 · cited 1×
“Maternal smoking [61] and alcohol exposure [62] during pregnancy are associated with increased ADHD risk, likely through neurotoxic effects on fetal development.”
Chan, E. S. M., & Langberg, J. M. (2026) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-024-10259-y · Cited by 11 · cited 3×
“The clinical relevance of these deficits is high; adults exhibiting multiple EF impairments often report greater academic and occupational difficulties [93,97].”
Zaleski, A. L., Craig, K. J. T., Khan, R., Waber, R., Xin, W., Powers, M., Ramey, U., Verbrugge, D. J., & Fernandez-Turner, D. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13296-2 · Cited by 11 · cited 1×
“Across studies, 15–50% of adults with ADHD exhibit autistic traits or meet ASD diagnostic thresholds, while 15–35% of adults with ASD also fulfill ADHD [42,43].”
Alaghband-rad, J., Dashti, B., Tehranidoost, M., Zargarinejad, G., & FarhadBeigi, P. (2021) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000001247 · Cited by 10 · cited 1×
“Deficits are frequently observed in sustained and divided attention, planning and set-shifting (e.g., Tower of London), response inhibition (e.g., Continuous Performance Test), and interference control (e.g., Stroop) [92,93,96].”
Jung, B., Ahn, K., Justice, C., Norman, L., Price, J., Sudre, G., & Shaw, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01906-y · Cited by 10 · cited 1×
“Neurochemical and genetic studies further suggest heterogeneity: men may carry a greater burden of rare structural variants, whereas women may require a higher polygenic threshold to manifest ADHD [136]—supporting a proposed female protective effect.”
Faraone, S. V., Ward, C. L., Boucher, M., Elbekai, R., & Brunner, E. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106275 · Cited by 10 · cited 1×
“The serotonergic (5-HT) system has also been implicated, particularly in relation to impulsivity and the high rates of comorbid mood and anxiety disorders [71].”
Ni, M., Li, L., Li, W., Zhang, Q., Zhao, J., Shen, Q., Yao, D., Wang, T., Li, B., Ding, X., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1074783 · Cited by 9 · cited 2×
“Maternal smoking [61] and alcohol exposure [62] during pregnancy are associated with increased ADHD risk, likely through neurotoxic effects on fetal development.”
Vera, J. D., Freichel, R., Michelini, G., Loo, S. K., & Lenartowicz, A. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241253999 · Cited by 9 · cited 1×
“Neuroimaging evidence indicates that individuals with this condition exhibit smaller cerebellar volumes and altered cerebellar connectivity, which likely contribute to attentional lapses and challenges in cognitive regulation [81,82].”
Sogard, A. S., & Mickleborough, T. D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.978336 · Cited by 8 · cited 1×
“Optimal pharmacotherapy should consider individual symptom profiles, comorbidities (e.g., anxiety, substance use, sleep disorders), lifestyle, and treatment history [153].”
Seery, C., Leonard-Curtin, A., Naismith, L., King, N., O'Donnell, F., Byrne, B., Boyd, C., Kilbride, K., Wrigley, M., McHugh, L., et al. (2024) · BJPsych Open · doi:10.1192/bjo.2024.743 · Cited by 8 · cited 1×
“Similarly, the DASH (Dietary Approaches to Stop Hypertension) diet, which emphasizes whole foods and low sodium, has shown potential cognitive benefits in preliminary studies [187].”
Early Predictors of De Novo and Subthreshold Late-Onset ADHD in a Child and Adolescent Cohort
Liu, C.-Y., Asherson, P., Viding, E., Greven, C. U., & Pingault, J.-B. (2021) · Journal of Attention Disorders · doi:10.1177/1087054719892888 · Cited by 8 · cited 1×
“These challenges are associated with lower academic performance and higher rates of educational failure compared to neurotypical peers [8,9].”
Moldekleiv, C. D., Lundervold, A. J., Solberg, B. S., Engeland, A., Fadnes, L. T., Chalabianloo, F., & Klungsøyr, K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07305-1 · Cited by 8 · cited 1×
“Comorbidity confers a more severe clinical profile, including higher rates of polysubstance use, emergency visits, suicidality, and treatment dropout [108].”
Strålin, E. E., Thorell, L. B., Lundgren, T., Bölte, S., & Bohman, B. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1564506 · Cited by 8
Gaur, S., & Pallanti, S. (2020) · Cureus · doi:10.7759/cureus.9814 · Cited by 8 · cited 1×
“Support groups create structured environments for peer exchange and normalization of experience, reducing isolation and enhancing resilience [167].”
Pan, N., Ma, T., Liu, Y., Zhang, S., Hu, S., Shekara, A., Cao, H., Gong, Q., & Chen, Y. (2024) · Psychological Medicine · doi:10.1017/s003329172400285x · Cited by 7 · cited 1×
“Tailoring pharmacotherapy to comorbidity patterns—such as anxiety, insomnia, or cardiovascular disease—enhances both safety and efficacy [155,158].”
Seery, C., Cochrane, R. H., Mulcahy, M., Kilbride, K., Wrigley, M., & Bramham, J. (2025) · Internet Interventions · doi:10.1016/j.invent.2025.100807 · Cited by 7 · cited 1×
“Clinical studies demonstrate meaningful reductions in ADHD symptom severity, impulsivity, and comorbid anxiety, alongside improvements in quality of life [168].”
Effect of stimulants on final adult height
Wojnowski, N. M., Zhou, E., & Jee, Y. H. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0344 · Cited by 6 · cited 1×
“Concerns regarding misuse and diversion remain relevant, particularly among young adults and university populations [150].”
Bedawi, R. M., Al-Farsi, Y., Mirza, H., Al-Huseini, S., Al-Mahrouqi, T., Al-Kiyumi, O., Al-Azri, M., & Al-Adawi, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050566 · Cited by 6 · cited 2×
“In clinical and community samples of adults with ADHD, the combined presentation is by far the most common, accounting for roughly 63.5% of cases [89].”
InfluentialFrequency of binge eating in medication adherent patients with ADHD and its relation to impulsivity
Shaker, N. M., Mahmoud, D. A. M., Ahmed, M. M., & Rabie, E. S. (2025) · Middle East Current Psychiatry · doi:10.1186/s43045-025-00521-1 · Cited by 5 · cited 2×
“Evidence also links ADHD with binge-eating behaviors and bulimia, with a prevalence of 9–30% [109,110].”
Weusten, L. H., Heijnen-Kohl, S. M. J., Ellison, J., & van Alphen, S. P. J. (2014) · International Psychogeriatrics · doi:10.1017/s1041610213001816 · Cited by 4 · cited 1×
“Meta-analyses report moderate efficacy, particularly for attentional domains, though methodological heterogeneity limits definitive conclusions [169].”
Kazarov, C., Peasah, S. K., McConnell, E., Fischer, K. K., & Good, C. B. (2024) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001296 · Cited by 4 · cited 4×
“Atomoxetine, a selective norepinephrine reuptake inhibitor (NRI), enhances NE transmission in prefrontal circuits regulating attention and inhibition [154,155].”
InfluentialAdult attention deficit/hyperactivity disorder in the ambulatory care setting
Hackett, A., Joseph, R., Robinson, K., Welsh, J., Nicholas, J. S., & Schmidt, E. (2020) · JAAPA · doi:10.1097/01.jaa.0000684108.89007.52 · Cited by 4
Review of Cardiovascular Effects of ADHD Medications
Levin, C. J., Goodman, D. W., & Adler, L. A. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180612-01 · Cited by 3 · cited 1×
“These effects are usually dose-dependent and manageable, but rare cardiovascular events necessitate risk stratification and ongoing monitoring, especially in patients with preexisting cardiac conditions [149].”
Sparle Christensen, K., Storebø, O. J., & Bach, B. (2025) · Journal of Attention Disorders · doi:10.1177/10870547241312575 · Cited by 3 · cited 1×
“The Adult ADHD Self-Report Scale (ASRS) and its short forms provide efficient identification of probable cases and demonstrate strong specificity and reliability (~0.90 Cronbach’s alpha) [31,118].”
InfluentialPark, S., & Park, S. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241253151 · Cited by 2
Baby, M., Priya, V., Pallavi, J., Karthik Chand, B., Srinivasan, L., Rana, S., Tawil, S., Haque, S., Ghosh, P., Bhattacharya, P., et al. (2025) · International Journal of Women's Health · doi:10.2147/ijwh.s511297 · Cited by 2 · cited 1×
“Personality disorders, particularly borderline and antisocial, frequently co-occur, with estimates suggesting up to 16–38% prevalence [107,111].”
Tan, X., Xu, Y., Wang, S., Li, J., Hu, C., Chen, Z., Cheng, Q., & Wang, Z. (2023) · doi:10.37766/inplasy2023.9.0059 · Cited by 2
To Prescribe or Not? Pharmacological Options in Adult Attention-Deficit/Hyperactivity Disorder
Aoshima-Kilroy, A., Banu, S., Udoetuk, S., Shah, A. A., & Moukaddam, N. (2017) · Psychiatric Annals · doi:10.3928/00485713-20170510-01 · Cited by 1 · cited 1×
“By inhibiting DA and NE reuptake and facilitating presynaptic release, stimulants normalize the deficient cortical arousal and signal-to-noise ratios characteristic of ADHD [145].”
Pharmacological treatment of ADHD in children and adults
Thomsen, P. H., Houmann, T., & Ishøy, P. L. (2025) · Ugeskrift for Læger · doi:10.61409/v10240755 · Cited by 1
Schoeman, R., & Klerk, M. D. (2017) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v23i0.1010
Research works printed but not linked: 9
- Hrys, 2024, Aдaптaцiйний пoтeнцiaл ociб дopocлoгo вiкy з poзлaдoм дeфiцитy yвaги/гiпepaктивнocтi (PДУГ), Insight Psychol. Dimens. Soc., 12, 471
- Takizawa, 2013, Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults, Neuroimage Clin., 4, 53
- Cubillo, 2006, Executive dysfunctions in adults with attention deficit hyperactivity disorder, Rev. Neurol., 43, 678
- 2012, Cognitive and executive functions in ADHD, Actas Esp. Psiquiatr., 40, 293
- (2025, August 06). Table 7, DSM-IV to DSM-5 Attention-Deficit/Hyperactivity Disorder Comparison, Available online: https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t3/.
- (2025, August 10). Treatment in adult ADHD|Oxford Textbook of Attention Deficit Hyperactivity Disorder|Oxford Academic. Available online: https://academic.oup.com/book/24517/chapter-abstract/187669990?redirectedFrom=fulltext.
- Knecht, 2015, Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder, Neuropsychiatr. Dis. Treat, 11, 1359
- Biederman, 2006, The Effects of Attention-Deficit/Hyperactivity Disorder on Employment and Household Income, MedGenMed, 8, 12
- 2022, Marital Adjustment and Marital Conflict in Individuals Diagnosed with ADHD and Their Spouses, Noro Psikiyatr Ars, 59, 127
Cited by
Dietary Carbohydrates and ADHD Symptoms: A Systematic Review
Panayotova, G. G., & Hachmeriyan, A. (2026) · Nutrients · doi:10.3390/nu18101625 · Cited by 2
Petropoulos, A., Pergantis, P., Drosos, K., & Tafiadis, D. (2026) · Nutrients · doi:10.3390/nu18162664 · Cited by 2
“We emphasize that despite their clinical significance, communication difficulties in ADHD remain underrecognized and are frequently interpreted solely as secondary consequences of attentional dysfunction [16].”
Agboji, H., Obanye, J., & Agboji, A. (2026) · Psychiatry International · doi:10.3390/psychiatryint7020064 · Cited by 1
A review of attention-deficit/hyperactivity disorder: Causes, diagnosis, treatment, and impact
Bamgboye, O. C., Busari, S. M., Muojekwu, C. G., Obe, N. M., Owojuyigbe, V. O., Oyeleke, N. M., Chinyere, K. F., Adegbola, P. I., Lawrence, A., & Adekeye, A. O. (2026) · Acta Psychologica · doi:10.1016/j.actpsy.2026.107744
Neurodevelopmental reward dysregulation and addiction risk in ADHD
Custodio, R. J. P., Yi, E. C., Kim, B.-N., & Cheong, J. H. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02370-3
Metadata
- Authors
- Bogdańska-Chomczyk, E., Majewski, M. K., & Kozłowska, A.
- Affiliations
- University of Warmia and Mazury in Olsztyn (PL)
- Corresponding author
- Kozłowska, Anna
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2025-11-14
- Volume
- 26
- Issue
- 22
- Pages
- 11020
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12652008
- OpenAlex
- W4416199620
- Semantic Scholar
- aede940d934f405290b6edd2696c76e5237e1e79
- Cited by
- 15
- References
- 185
- Citations by year
- 2026: 15
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- The Minister of Science under “The Regional Initiative of Excellence Program” (RID/SP/0025/2024/01)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- adult ADHD, attention deficit hyperactivity disorder, comorbidities, mood disorders, anxiety disorders, substance use disorders, executive dysfunction, emotional dysregulation, pharmacotherapy, cognitive behavioral therapy, integrated care, quality of life, occupational functioning, social functioning, etiology, diagnosis
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Humans, Quality of Life, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
